Ullmann Claudio Dansky
CIK: 0002030789
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CNTX
Context Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
About Dansky Ullmann Claudio
Dansky Ullmann Claudio (SEC CIK 0002030789) files insider reports with the SEC as Chief Medical Officer of Context Therapeutics Inc. (CNTX).
Signal8 holds 1 ownership filing by Dansky Ullmann Claudio, a Form 4, filed on Feb 14, 2025. Those filings report 1 transaction, the latest on Feb 13, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Dansky Ullmann Claudio's filings is in PHILADELPHIA, PA.
Recent filings by Dansky Ullmann Claudio
- Feb 13, 2025: Grant or award of CNTX derivative securities (Form 4, code A).
Other insiders filing for Context Therapeutics Inc. (CNTX)
- Pasternak Andy, Director
- Stacey Jennifer Evans, Director
- West Linda, Director
- Smith Karen L., Director
- Walker Luke Nathaniel, Director
- Kantoff Philip W., Director